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In conclusion: Pts traditionally considered thrombolytic eligible comprise a
low risk cohort, and have a favorable prognosis whether treated with primary
PTCA or t-PA. In contrast, pts historically excluded from most early lytic trials
because of advanced age, late presentation or prior CABG are at increased
risk, and may have improved survival with primary PTCA rather than throm-
bolysis.
Exercise Training in Postinfarction Patients with
Left Ventricular Dysfunction. Preliminary
Results of the Exercise in Left Ventricular
Dysfunction (ELVD) Trial
Differential Effects of Long-term Beta-Blocker
Therapy Following Thrombolysis versus
Primary Angioplasty
Follow-up Events Propranolol Placebo p-value
In = 317) (n = 339) (Cox regression)
Overall mortality 7.6% 13.6% 00078
Sudden death 4.7% 9.7% 00094
Definite or probable MI 3.8% 7.7% 0.037
MI andlor mortality 9.2% 17.4% 0.0011
ocardial infarction (AMI) who have persistent electrocardiographic (ECG) ST
segment depression (STD) are at high risk for future cardiac events when
compared with AMI pts without STD. There are little data on the long term
effects of medical therapy on acute MI pts with STD. The objectives of this
retrospective analysis were to examine in the Beta Blocker Heart Attack Trial
(BHAT) the effects of propranolol in this high risk group. Of the 2877 first MI
BHAT pts, 656 pts had persistent ECG STD from the time of admission until
randomization (9.7 ± 3.1 days after index MI). Of these, 317 pts were ran-
domized to the propranolol and 339 pts to placebo. There were no significant
baseline differences (p < 0.05) between the two groups. The median follow
up was 24.6 months.
Cox regression analysis, adjusting for baseline variables showed the rel-
ative risk of mortality and the relative risk of sudden death were 2.13 (1.22,
3.70) and 2.56 (1.27, 5.26) respectively in the placebo, compared to the pro-
pranolol group. It appears that propranolol therapy is effective in reducing
cardiac events in pts recovering from an AMI with ECG STD.
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The effects of chronic beta-blocker therapy (BBT) following reperfusion ther-
apy for myocardial infarction IMI) are unclear. To address this question, we
evaluated the long-term effects of BBT on patients (pts) in the PAMI study.
A total of 395 pts were raandomized to thrombolysis (t-PA) or primary angio-
plasty (PTCA); 20 pts (5%) were lost to follow-up. Mean follow-up averaged
24 months. 42% of pts in both groups received long-term BBT. The groups
with BBT I$BBT) and without BBT (8BBT) for both PTCA and t-PA treated
arms were similar with respect to age, gender, ejection fraction, hyperten-
sion, diabetes, lipids, smoking, etc.
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Aim of this multicenter randomized study was to investigate whether long-
term physical training would influence left ventricular remodeling and func-
tion in patients (pts) with systolic dysfunction after myocardial infarction (MI).
Forty-three consecutive pts (51 ± 8 years) with :0:40% ejection fraction (EF)
and no contraindications to exercise, in I-II NYHA Class, were studied 3-5
weeks after a first Q-wave M I and 6 months later by 2D-ECHO at rest and
upright symptom-limited bicycle ergometric test. After the initial study, pts
were randomly allocated to a 6-month exercise training program (T. n 22)
or control (C, n 21). A computerized system was used to derive echocar-
diographic variables of ventricular size, function and topography. At entry,
work capacity (WC). end-diastolic (EDV) and end-systolic (ESV) volumes, EF,
extent of wall motion abnormalities (%WMA) and regional dilatation (%RD)
were similar in the two groups. After 6 months, a significant increase in WC
was observed only in T (from 4,527 ± 1,107 to 5,529 ± 1,828 Kp-m, p < 0.01)
and not in C (from 4,371 ± 1,143 to 4,268 ± 1,199 Kp-m, NS), whereas LV
volumes and %RD increased in C IEDV: from 86 ± 24 to 95 ± 29 ml!m2, p
< 0.01; ESV: from 58 ± 21 to 66 ± 26 ml/m2 , p < 0.01; %RD: from 47 ± 18
to 57 ± 22, p < 0.01) but not in T IEDV: from 84 ± 21 to 85 ± 22 ml!m2, NS;
ESV: from 56 ± 17 to 54 ± 19 ml!m2, NS; %RD: from 43 ± 18 to 45 ± 26,
NS). Conversely, %WMA decreased and EF improved in T (%WMA: from 48
± 8 to 43 ± 10, P < 0.01; EF: from 34 ± 5 to 38 ± 8%, P < 0.01), but not in
C (%WMA: from 47 ± 9 to 48 ± 12, NS; EF: from 33 ± 5 to 32 ± 7%, NS).
Thus, from these preliminary data it appears that in postinfarction pts with
poor left ventricular function long-term exercise training may attenuate the
unfavorable remodeling response and even improve both global and regional
function over time.
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Stress Echo and the Risk of Reinfarction: A
Fatal Attraction?
Thrombolytic eligible Thrombolytic ineligible
PTCA l-PA P PTCA t-PA P
In = 1271 In = 117) (n = 68) In = 831
in-hosp. D 2.4% 1.7% NS 2.9% 13.3% 0.025
in-hosp. D or R 5.5% 9.4% NS 4.4% 15.7% 0.026
in-hosp. RIE 11.8% 29.1% 0.0008 7.4% 26.6% 0.002
in-hasp. stroke 0% 1.7% NS 0% 6.0% 0.04
6 month D 3.9% 1.7% NS 2.9% 15.7% 0.009
6 month D or R 8.7% 12.8% NS 7.4% 22.9% 0.009
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traditionally considered lytic "eligible" vs. "ineligible" (age> 70, MI onset >4
hours, or prior CABG). we examined the PAMI database in which 395 pts of
any age within 12 hours onset of MI were randomized tot-PA or primary PTCA
(pts with shock were excluded). Compared to lyric eligible pts, ineligible pts
were 01der(67 vs. 56 yrs, p < 0.0001). more frequently female (38% vs. 20%,
P < 0.00011. diabetic (17% vs. 10%, P = 0.03), had prior CABG (8% vs. 0%,
P < 0.0001). presented later (4.4 vs. 2.2 hours, p < 0.0001), and were more
likely to present in CI-1F (20% vs. 11%, P = 0.01). Endpoints included death
(D), reinfarction (R). recurrent ischemic events (RIE) and stroke:
Rosa Sicari, Alessandro Pingitore, Giovanni Minardi, Nicola Gandolfo,
Giovanni Seveso, Francesco Chiarella, Leonardo Bolognese, Giacomo Chiaranda,
Nunzia Petix, Maria Grazia Sciavo, Mario Previtali, Franca Margaria, Omelia Magaia,
Federico Bianchi, Salvatore Pirelli, Luis Felipe de Moura Duarte, Maria Jose de
Sousa, Silva Severi, Mauro Raciti, Patrizia Landi, Eugenio Picano, EPIC (Echo
Persantine Italian Cooperative) study group. CNR, Institute of Clinical Physiology.
Pisa, Italy
The identification of future reinfarction seems an elusive target for physio-
logic testing, consistently with the accepted notion that it is plaque type,
rather than plaque size, that matters in provoking coronary occlusion. How-
ever, large sample populations are needed to detect phenomena with a low
event rate. In addition, one should employ noninvasive stress test results
that are tightly related to the extent and severity of CAD - in a stronger way
than exercise-ECG. Aim of this study was to assess the capability of dipyri-
damole echocardiography test (DET) to predict reinfarction in patients eval-
uated early after acute uncomplicated myocardial infarction. In an updated
analysis of the EPIC Study, we assessed the value of DET in predicting rein-
farction in 1080 pts (age = 56 ± 9, 926 men and 154 women) evaluated early
(10 ± 5 days) after uncomplicated acute myocardial infarction and followed
up for 14 ± 10 months. A positive test occurred in 475 pts (44%). During
follow-up, there were 50 reinfarctions: 45 non-fatal, and 5 fatallfollowed by
cardiac death after :0:4 days from the reinfarction). Reinfarction (either non-
fatal or fatal) occurred in 30 pts with positive and in 20 with negative DET
(6.3 vs 3.3%, p < 0.01). Nonfatal reinfarction occurred in 25 patients with
positive and in 20 with negative DET (5 vs 3%, P = 0.05). Reinfarction was
fatal in 5 out of 25 reinfarcted patients with positive and in none out of 20
reinfarcted patients with negative DET (20 vs 0%, P = 0.07). The relative risk
li.e., the relative risk of the occurrence of future cardiac events in the group
with negative DET) of reinfarction was 1.9.
In conclusion, DET positivity identifies patients evaluated early after un-
complicated myocardial infarction at higher risk of reinfarction and especially
of fatal reinfarction.
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Effects of Propranolol in Patients with Their
First Acute Myocardial Infarction and Persistent
Electrocardiographic ST Segment Depression
in the Beta Blocker Heart Attack Trial
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Ford Heart and Vascular Institute, Detroit, MI; Northwestern University Medical School,
Chicago,lL
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The available data suggest that patients (pts) recovering from an acute my-
